VALIDATION OF A RISK PREDICTION MODEL FOR IN-HOSPITAL MORTALITY FOLLOWING PEDIATRIC HEART TRANSPLANTATION  by Almond, Christoher S.d. et al.
A46.E443
JACC March 9, 2010
Volume 55, issue 10A
  CONGENITAL CARDIOLOGY SOLUTIONS
 (PEDIATRIC CARDIOLOGY AND ADULT CONGENITAL HEART DISEASE)
VALIDATION OF A RISK PREDICTION MODEL FOR IN-HOSPITAL MORTALITY FOLLOWING PEDIATRIC 
HEART TRANSPLANTATION
ACC Poster Contributions
Georgia World Congress Center, Hall B5
Tuesday, March 16, 2010, 9:30 a.m.-10:30 a.m.
Session Title: Transplantation and Other Advanced Cardiac Therapies in Children
Abstract Category: Pediatric Cardiology
Presentation Number: 1281-408
Authors: Christoher S. d. Almond, Kimberlee Gauvreau, Charles E. Canter, Gary E. Piercey, TP Singh, Children’s Hospital Boston, Boston, MA, St. Louis 
Children’s Hospital, St. Louis, MO
Background: Risk factors for early post-transplant mortality in children undergoing heart transplant (HT) have been previously described. However, 
a quantitative risk-prediction model based on these factors has not been validated.
Methods: We developed and validated a risk-prediction model for in-hospital mortality for children undergoing HT using OPTN data. All U.S. 
children age <18 years who underwent primary HT between 1999 and 2009 were included. Logistic regression analysis was used to develop a 
prediction model using two-thirds of the cohort which was validated in the remaining one third.
Results: Of 2745 children, the model was developed using a random sample of 1830 children (with 7.8% pre-discharge mortality) and applied to 
the remaining 915 children (with 6.5% mortality) for validation. The model contained 5 categorical variables: ECMO, ventilator, CHD, GFR<40 ml/
min/m2, and dialysis. The C-statistic (0.76) and the Hosmer-Lemeshow (HL) goodness-of-fit (P=0.37) statistics in the model-development cohort 
were replicated in the validation cohort (C-statistic 0.74 and the HL goodness-of-fit P=0.54) suggesting acceptable predictive ability.
Conclusions: This risk prediction model using 5 baseline clinical factors at the time of transplant has acceptable prediction characteristics 
for post-transplant in-hospital mortality. The model may be useful in decision-making for listing, for timing of mechanical support and defining 
transplant futility.
